Ind-Swift Laboratories Limited (INDSWFTLAB)
ISIN: - Industry: Drug Manufacturers—Specialty & Generic Sector: Healthcare Website
61.2
0.65(1.07%)

Ind-Swift Laboratories Limited develops, manufactures, and sells active pharmaceutical ingredients (APIs) in India. The company offers APIs in various therapeutic areas, including macrolide antibiotic, cardiovascular, antihistaminic, antidiabetic, antipsychotic, bone resorption inhibitor, antimigraine, Parkinson disease, hyperparathyrodism, analgesic, aromatase inhibitor, nootropic, antidiarrhoeal/antiprotozoal, anticholinergic, sedative, hypnotic, alcohol abstinence, and antineoplastic, as well as various products for ADHD symptoms. It provides reference standards and impurities for acamprosate calcium, anastrozole, aripiprazole, aripiprazole, atorvastatin calcium, bexarotene, cinacalcet hydrochloride, clopidogrel bisulphate, Clarithromycin, ezetimibe, fexofenadine hydrochloride, imatinib mesylate, ivabradine hydrochloride, ivabradine oxalate, letrozole, mecloxamine citrate, naratriptan hydrochloride, nitazoxanide, quetiapine, ropinirole hydrochloride, rosuvastatin calcium, saxagliptin monohydrate, silodosin, and temozolomide. The company also offers early and late phase drug development, process research and development, contract and API manufacturing, and custom chemicals and synthesis; and analytical development, regulatory support, chemistry, impurity profiling, isolation, discovery, identification and characterization, and project management services. It also exports its products. Ind-Swift Laboratories Limited was founded in 1995 and is based in Manimajra, India.

Pricing Updates

TODAY'S HIGH

62.85

TODAY'S LOW

59.2

52 WEEK HIGH

127.45

52 WEEK LOW

55.05

Major Holders

% of Shares Held by
All Insider

67.98%

% of Shares Held by
Institutions

0.00%

% of Float Held by
Institutions

0.00%

Number of Institutions
Holding Shares

0

Company Overview

MARKET CAP

361.61 Cr.

ETERPRISE VALUE

1318.12 Cr.

NO. OF SHARES

5.90 Cr.

BOOK VALUE

109.44

DIV. YIELD

1%

DEBT

972.73 Cr.

GROSS PROFIT

455.32 Cr.

CASH

17.31 Cr.

REVENUE

975.43 Cr.

REVENUE/SHARE

165.054

OHLC Chart 1y 2y 5y 10y

Price Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Volumes Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Cashflows

ParticularsMar 2021Mar 2020Mar 2019Mar 2018
Investments-6.28 Cr.1.10 Cr.-24.72 Lakhs-14.96 Lakhs
Change To Liabilities0000
Total cashflows from Investing Activities-10.17 Cr.-9.09 Cr.-12.46 Cr.-17.40 Cr.
Net Borrowings-39.85 Cr.-65.74 Cr.161.29 Cr.-41.77 Cr.
Total Cash from Financing Activities-123.74 Cr.-133.25 Cr.99.62 Cr.-61.98 Cr.
Other Liabilities8.25 Cr.33.59 Cr.-221.37 Cr.-46.77 Cr.
Total Assets0052 Lakhs53.76 Lakhs
Net Income-3.14 Cr.-21.18 Cr.28.94 Cr.21.97 Cr.
Change in Cash1.02 Cr.-17.11 Cr.22.75 Cr.-6.29 Cr.
Effect of Exchange Rate0000
Total Cash from Operating Activities134.94 Cr.125.23 Cr.-64.39 Cr.73.09 Cr.
Depreciation55.16 Cr.90.05 Cr.104.04 Cr.86.61 Cr.
Other Cashflows from Investing Activities51.28 Lakhs58.72 Lakhs2.70 Cr.3.84 Cr.
Dividends Paid0000
Change to Inventory-32.84 Cr.-26.20 Cr.-6.56 Cr.26.64 Cr.
Change to Account Receivables-38.45 Cr.-38.39 Cr.13.13 Cr.-48.28 Cr.
Other Cashflows from Financing Activities-83.89 Cr.-67.51 Cr.-62.19 Cr.-20.74 Cr.
Change to Net Income113.21 Cr.87.37 Cr.20 Cr.32.91 Cr.
Capital Expenditures-3.91 Cr.-10.74 Cr.-15.25 Cr.-20.45 Cr.

Financials

ParticularsMar 2021Mar 2020Mar 2019Mar 2018
Research DevelopmentNoneNoneNoneNone
Effect of Accounting ChargesNoneNoneNoneNone
Income Before Tax18 Cr.-19.77 Cr.49.67 Cr.35.98 Cr.
Minority Interest-8.97 Lakhs-8.97 Lakhs-8.97 Lakhs-8.97 Lakhs
Net Income110.95 Cr.73.95 Cr.44.48 Cr.62.14 Cr.
Selling General Administrative107.85 Cr.105.84 Cr.101.80 Cr.96.29 Cr.
Gross Profit455.32 Cr.402.68 Cr.375.65 Cr.386.35 Cr.
Ebit110.95 Cr.73.95 Cr.44.48 Cr.62.14 Cr.
Operating Income110.95 Cr.73.95 Cr.44.48 Cr.62.14 Cr.
Other Operating Expenses149.22 Cr.132.82 Cr.125.31 Cr.141.29 Cr.
Interest Expense-93.35 Cr.-102.46 Cr.-83.95 Cr.-26.93 Cr.
Extraordinary ItemsNoneNoneNoneNone
Non RecurringNoneNoneNoneNone
Other ItemsNoneNoneNoneNone
Income Tax Expense21.15 Cr.1.41 Cr.20.73 Cr.14.01 Cr.
Total Revenue906.77 Cr.799.34 Cr.779.01 Cr.776.91 Cr.
Total Operating Expenses795.81 Cr.725.38 Cr.734.52 Cr.714.76 Cr.
Cost of Revenue451.44 Cr.396.66 Cr.403.36 Cr.390.56 Cr.
Total Other Income Expense Net-92.95 Cr.-93.73 Cr.5.18 Cr.-26.15 Cr.
Discontinued OperationsNoneNoneNoneNone
Net Income from Continuous Ops.-3.14 Cr.-21.18 Cr.28.94 Cr.21.97 Cr.
Net Income Applicable to Common Shares-3.14 Cr.-21.18 Cr.28.94 Cr.21.97 Cr.

Balance Sheet

ParticularsMar 2021Mar 2020Mar 2019Mar 2018
Intangible Assets9.20 Cr.40.84 Cr.75.93 Cr.125.68 Cr.
Capital Surplus307.31 Cr.307.31 Cr.243.38 Cr.232.06 Cr.
Total Liabilities1215.03 Cr.1229.37 Cr.1336.14 Cr.1469.74 Cr.
Stock Holder Equity603.50 Cr.640.63 Cr.587.81 Cr.553.24 Cr.
Minority Interest-8.97 Lakhs000
Other Liabilities34.60 Cr.28.10 Cr.30.13 Cr.11.91 Cr.
Total Assets1818.44 Cr.1870 Cr.1923.96 Cr.2022.98 Cr.
Common Stock59.08 Cr.59.08 Cr.47.56 Cr.45.27 Cr.
Retained Earnings61.34 Cr.49.24 Cr.57.18 Cr.20.61 Cr.
Other Liabilities15.90 Cr.14.95 Cr.14.56 Cr.13.32 Cr.
Good Will21.13 Lakhs21.13 Lakhs21.13 Lakhs21.18 Lakhs
Treasury Stock175.76 Cr.224.99 Cr.239.66 Cr.255.27 Cr.
Other Assets81.24 Cr.149.98 Cr.146.43 Cr.172.21 Cr.
Cash11.60 Cr.10.58 Cr.29.96 Cr.9.44 Cr.
Current Liabilities314.52 Cr.323.06 Cr.356 Cr.935.92 Cr.
Long Term Asset Charges60.35 Cr.77.97 Cr.78.82 Cr.96.01 Cr.
Short Long Term Debt47.98 Cr.57.01 Cr.90.11 Cr.251.25 Cr.
Other Stockholder Equity175.76 Cr.224.99 Cr.239.66 Cr.255.27 Cr.
Property Plant Equipment748.08 Cr.798.49 Cr.844.92 Cr.864.23 Cr.
Total Cur. Assets944.18 Cr.863.02 Cr.836.08 Cr.842.32 Cr.
Long Term Investments35.52 Cr.17.45 Cr.20.36 Cr.18.31 Cr.
Net Tangible Assets594.09 Cr.599.58 Cr.511.66 Cr.427.34 Cr.
Short Term Investments0000
Net Receivables478.23 Cr.420.51 Cr.371.79 Cr.419.85 Cr.
Long Term Debt884.12 Cr.890.88 Cr.965.57 Cr.520.49 Cr.
Inventory375.66 Cr.342.81 Cr.316.60 Cr.316.91 Cr.
Accounts Payable138.82 Cr.135.22 Cr.126.67 Cr.128.63 Cr.

New Offers


Upstox offer
Upstox

Open a demat account through us and get the account opening charges waived off

open paperless account